Skip to main content
. 2024 Feb 23;34(3):449–459. doi: 10.1055/s-0044-1779266

Table 3. Table of patients.

Patient Age at presentation (y) Gender Location Size of lesion at presentation (cm 2 ) Final score (4–20) a Final grade (1–4) a Duration of follow-up (mo)
1 32 Male Proximal femur 15 12 2 >24
2 18 Male Proximal femur 22.6 8 3 >24
3 21 Male Pubic bone 9.8 4 4 >24
4 9 Male Pubic bone 9.5 11 2 >24
5 7 Male Scapula 32.8 7 3 >24
6 12 Female Ulna 5 7 3 >24
7 13 Female Fourth metatarsal 14.6 7 3 >24
8 13 Female Pubic bone 598.6 4 4 12-24
9 8 Male Humerus 29 7 3 >24
10 14 Female Clavicle 14.3 16 1 12–24
11 23 Female Second metatarsal 1.4 7 3 12–24
12 16 Female Pubic bone 13.6 7 3 12–24
13 21 Male Pubic bone 27 4 4 >24
14 27 Female Proximal femur 13.6 7 3 12–24
15 26 Female Proximal femur 49.5 7 3 12–24
16 16 Male C3 posterior elements 1.05 4 4 12–24
17 33 Male Fibular head 50.4 7 3 12–24
18 20 Male Talus 18.5 8 3 12–24
19 26 Male Proximal femur 23 7 3 12–24

Note: All patients received three sessions of computed tomography-guided sclerotherapy with doxycycline and albumin.

a

Royal Orthopaedic Hospital score or grade at the time of final follow-up.